Why BPC-157 + TB-500 Is the Go-To Healing Stack
BPC-157 and TB-500 are the two most widely used healing peptides, and for good reason — they address tissue repair through complementary mechanisms that produce results neither compound achieves alone.
BPC-157 (Body Protection Compound-157) is a synthetic peptide derived from a protein found in human gastric juice. It works primarily through localized mechanisms:
- Promotes angiogenesis (new blood vessel formation) at the injury site
- Accelerates tendon, ligament, muscle, and bone healing
- Protects and heals the GI tract (effective for gut issues, ulcers, and IBS)
- Modulates nitric oxide pathways for anti-inflammatory effects
- Has demonstrated neuroprotective properties
TB-500 (Thymosin Beta-4) is a synthetic version of a naturally occurring 43-amino-acid peptide. It works systemically:
- Upregulates actin, a cell-building protein essential for tissue repair
- Promotes cell migration to injury sites
- Reduces inflammation throughout the body
- Improves flexibility and range of motion in injured tissues
- Supports cardiac tissue repair and remodeling
Together, BPC-157 provides targeted, localized repair while TB-500 creates a systemic healing environment. The combination accelerates recovery beyond what either peptide delivers individually.
Who This Protocol Is For
- Athletes recovering from soft tissue injuries (strains, sprains, tendinitis)
- Individuals with chronic joint pain or tendon issues
- Post-surgical recovery support (with physician approval)
- Those with GI issues (IBS, leaky gut, gastric ulcers) — BPC-157 is particularly effective here
- Anyone with nagging injuries that have not responded to conventional treatment
Detailed Dosing Schedule
Loading Phase (Weeks 1-3)
| Day | BPC-157 | TB-500 |
|---|---|---|
| Monday | 250-500mcg AM + PM | 2-5mg |
| Tuesday | 250-500mcg AM + PM | — |
| Wednesday | 250-500mcg AM + PM | — |
| Thursday | 250-500mcg AM + PM | 2-5mg |
| Friday | 250-500mcg AM + PM | — |
| Saturday | 250-500mcg AM + PM | — |
| Sunday | 250-500mcg AM + PM | — |
Maintenance Phase (Weeks 4-8)
| Day | BPC-157 | TB-500 |
|---|---|---|
| Monday | 250-500mcg AM + PM | 2-5mg |
| Tuesday | 250-500mcg AM + PM | — |
| Wednesday | 250-500mcg AM + PM | — |
| Thursday | 250-500mcg AM + PM | — |
| Friday | 250-500mcg AM + PM | — |
| Saturday | 250-500mcg AM + PM | — |
| Sunday | 250-500mcg AM + PM | — |
BPC-157 Injection Strategy
The key advantage of BPC-157 is its ability to work locally when injected near the injury:
- For muscle/tendon/joint injuries: Inject subcutaneously as close to the injury site as possible. You do not need to inject directly into the muscle or joint — subcutaneous injection in the overlying skin is sufficient.
- For gut issues: Inject subcutaneously in the abdominal area, or take orally. Oral BPC-157 (500mcg-1mg dissolved in water, taken on an empty stomach) has shown effectiveness for GI applications due to BPC-157's gastric origin.
- For general recovery: Abdominal subcutaneous injection is the standard default site.
TB-500 Works Systemically
Unlike BPC-157, TB-500 does not need to be injected near the injury. It circulates systemically and is recruited to sites of inflammation and damage. Inject wherever is most convenient — the abdomen is the most common choice.
The loading phase (2x/week) is important for building tissue levels of Thymosin Beta-4 before transitioning to a maintenance dose. Do not skip the loading phase.
Expected Recovery Timeline
- Days 1-3: Subtle reduction in inflammation and pain at the injury site
- Week 1: Noticeable decrease in swelling, improved range of motion, reduced pain levels
- Weeks 2-3: Significant healing progress. Many acute injuries (muscle strains, mild tendon issues) show substantial improvement
- Weeks 4-6: Advanced tissue remodeling. Chronic injuries begin showing meaningful improvement. Return to activity for many acute injuries.
- Weeks 6-8: Most acute-to-moderate injuries are significantly resolved. Chronic injuries show continued improvement.
Oral vs. Injectable BPC-157
BPC-157 is unique among peptides in that oral administration is viable for certain applications:
| Route | Best For | Dose | Notes |
|---|---|---|---|
| Subcutaneous injection | Localized injuries, musculoskeletal | 250-500mcg 2x/day | Inject near injury site |
| Oral (capsule or liquid) | GI issues, gut healing | 500mcg-1mg/day | Take on empty stomach |
| Subcutaneous (abdomen) | General recovery, systemic | 250-500mcg 2x/day | Default when no specific site |
Can You Combine BPC-157 and TB-500 in the Same Syringe?
Both peptides can be injected at the same time of day, but they should be drawn from separate vials using separate syringes. While some users combine them, mixing peptides in a single syringe risks degradation and contamination. The safest practice is two separate injections.
Safety Notes
- This is a well-tolerated combination with no known significant interactions between BPC-157 and TB-500.
- BPC-157 has an exceptional safety profile with virtually no reported serious side effects at standard doses.
- TB-500 is similarly well-tolerated. Rare reports include mild headache, lethargy, or head rush immediately after injection.
- Store reconstituted vials in the refrigerator at 36-46F (2-8C).
- Use each reconstituted vial within 30 days.
- Discard any vial that appears cloudy or contains particulate matter.
- Discontinue use if you experience any unusual reactions and consult your healthcare provider.
- This protocol is not a substitute for medical evaluation and treatment of injuries. Always have significant injuries assessed by a qualified medical professional.